Free Trial

Christopher Pasquale Analyst Performance

Analyst at Barclays

Christopher Pasquale is a stock analyst at Barclays focused in the healthcare sector, covering 10 publicly traded companies. Over the past year, Christopher Pasquale has issued 4 stock ratings, including buy and sell recommendations. While full access to Christopher Pasquale's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Christopher Pasquale's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
13 Last 9 Years
Buy Recommendations
69.23% 9 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy69.2%9 ratings
Hold23.1%3 ratings
Sell7.7%1 ratings

Out of 13 total stock ratings issued by Christopher Pasquale at Barclays, the majority (69.2%) have been Buy recommendations, followed by 23.1% Hold and 7.7% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
5 companies
NYSE
50.0% of companies on NYSE
5 companies

Christopher Pasquale, an analyst at Barclays, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
9 companies
90.0%
Industrials
1 company
10.0%

Christopher Pasquale of Barclays specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
9 companies
90.0%
PROFESSIONAL SERVICES
1 company
10.0%

Christopher Pasquale's Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
No ratings found for the selected criteria.